The start of the activities of the eighth Varma Forum and the ninth International Conference of Arab Pharmacists under the title "One health approach"

& nbsp;

& nbsp; One health approach & quot; under the auspices of the Egyptian Drug Authority and the Egyptian Authority for Unified purchase, supply, medical supply and medical technology management.

in the presence of Dr. Hisham State, Chairman of the Unified Purchase Authority, d. Hala Zayed, Regional Director of Medicines Company, d. Samer Al -Rifai, President of the Arab Association for Pharmacists and Secretary -General of the International Association for Pharmacists and Dr. Azza Agha, the former deputy head of the National Authority for the Quality of Education, Dr. Yassi Rajai, Assistant Chairman of the Egyptian Medicine Authority for Information Affairs and Investment Supervisor and the supervisor of the Central Administration for Pharmacy Welfare, and Dr. Osama Hatem, Associate Chairman of the Egyptian Pharmaceutical Authority for Policy Affairs and International Cooperation and the supervisor of the Central Administration for Pharmaceutical Policy and Markets Support, Dr. Mohamed Swailem, President of North Africa and Egypt Group in Pharmaceutical Company, d. Mohamed Hashmat, head of a company, and general manager of an Egyptian pharmaceutical company, d. Tamer Jerdana, Vice President and Director General of a Pharmaceutical Company, and a group of experts and leaders of the pharmaceutical industry in Egypt. Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Drug Authority, expressed his great happiness for his presence with this constellation of scholars and officials at the opening of this conference held under the title & quot; one health approach & quot;; That concept adopted by the World Health Organization to become a strategic framework links human health, animal health and environmental safety, in recognition of the close bonding and mutual influence between them, in a way that enhances our ability to achieve a sustainable health balance. Great such as infectious diseases, antibiotic resistance, food safety, sustainability of drug supplies, water and energy security, and environmental systems protection, all issues that require effort & collectively and cooperating between all sectors and specialties. Our dear homeland, and that the conference this year discusses one of the most important goals that the Egyptian state places at the heart of its interests, which is the localization of the drug industry, based on its regional and global leadership, as Egypt is the first African country to achieve the third level of maturity in organizing vaccines and medicines, within only 18 countries in the world, holding one of the highest levels of maturity according to the standards of the World Health Organization, the achievement that expresses our properties – in the Arab Republic of Egypt – For a stable, integrated drug regulatory system, works well, and enhances the position of the Egyptian Pharmaceutical Authority as a reference regulatory agency based on it and is incorporated at the advancement of the national pharmaceutical system. Thanks to the tremendous industrial capabilities that Egypt possesses, and its possession of more than 170 factories, 11 of them have international credits in the fields of manufacturing and quality such as the adoption of WHO and EMA, which produces the 2370 production lines, including 986 production lines, we have achieved distinguished proportions of drug self -sufficiency reached 91.3%. The localization of approximately 400 effective materials falls within 30 therapeutic groups, whose import bill is equivalent to 1.57 billion US dollars, and that this comes in addition to the authority’s readiness to announce the incentives of serious investment incentives, in order to encourage the partners of the national industry, while providing the organizational environment that encourages them to lead and innovate. Our researchers and distinguished scholars in the localization of the drug industry and the promotion of drug innovation; They constitute the link between scientific research and industrial application, from the discovery of effective vehicles, pharmaceutical design and the development of modern technologies to produce them, and to find technical solutions to any challenges that may face the pharmaceutical industry sector, which contributes to improving drug supply chains, reducing dependence on import, enhancing national pharmaceutical security, and supports our ability to respond to health challenges Establishment. Research, and we have a favorable opportunity to follow the approach of the major countries. Sustainability. By all the concerned authorities, under one umbrella, as a road map.

• For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and